An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems
Open Access
- 29 July 2020
- journal article
- research article
- Published by Springer Nature in EJNMMI Physics
- Vol. 7 (1) , 1-11
Abstract
Background: In addition to the structural information afforded by 1H MRI, the use of X-nuclei, such as sodium-23 (23Na) or phosphorus-31 (31P), offers important complementary information concerning physiological and biochemical parameters. By then combining this technique with PET, which provides valuable insight into a wide range of metabolic and molecular processes by using of a variety of radioactive tracers, the scope of medical imaging and diagnostics can be significantly increased. While the use of multimodal imaging is undoubtedly advantageous, identifying the optimal combination of these parameters to diagnose a specific dysfunction is very important and is advanced by the use of sophisticated imaging techniques in specific animal models. Methods: In this pilot study, rats with intracerebral 9L gliosarcomas were used to explore a combination of sequential multinuclear MRI using a sophisticated switchable coil set in a small animal 9.4 T MRI scanner and, subsequently, a small animal PET with the tumour tracer O-(2-[18F]-fluoroethyl)-L-tyrosine ([18F]FET). This made it possible for in vivo multinuclear MR-PET experiments to be conducted without compromising the performance of either multinuclear MR or PET. Results: High-quality in vivo images and spectra including high-resolution 1H imaging, 23Na-weighted imaging, detection of 31P metabolites and [18F]FET uptake were obtained, allowing the characterisation of tumour tissues in comparison to a healthy brain. It has been reported in the literature that these parameters are useful in the identification of the genetic profile of gliomas, particularly concerning the mutation of the isocitrate hydrogenase gene, which is highly relevant for treatment strategy. Conclusions: The combination of multinuclear MR and PET in, for example, brain tumour models with specific genetic mutations will enable the physiological background of signal alterations to be explored and the identification of the optimal combination of imaging parameters for the non-invasive characterisation of the molecular profile of tumours.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Application of31P MR Spectroscopy to the Brain TumorsKorean Journal of Radiology, 2013
- Simultaneous single‐quantum and triple‐quantum‐filtered MRI of 23Na (SISTINA)Magnetic Resonance in Medicine, 2012
- Feasibility of mapping the tissue mass corrected bioscale of cerebral metabolic rate of oxygen consumption using 17-oxygen and 23-sodium MR imaging in a human brain at 9.4TNeuroImage, 2010
- Comparison of 18F-FET and 18F-FDG PET in brain tumorsNuclear Medicine and Biology, 2009
- Quantitation of magnetic resonance spectroscopy signals: the jMRUI software packageMeasurement Science and Technology, 2009
- Metabolic Imaging by Hyperpolarized 13C Magnetic Resonance Imaging for In vivo Tumor DiagnosisCancer Research, 2006
- Practical design of a 4 Tesla double-tuned RF surface coil for interleaved 1H and 23Na MRI of rat brainJournal of Magnetic Resonance, 2006
- O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology, 2006
- O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomasBrain, 2005
- Non-Invasive Methods for Studying Brain Energy Metabolism: What They Show and What It MeansDevelopmental Neuroscience, 2000